5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity
- 1 August 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (15), 4021-4025
- https://doi.org/10.1016/j.bmcl.2006.05.010
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell lineOncogene, 2004
- Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline InhibitorJournal of Biological Chemistry, 2002
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline InhibitorsJournal of Medicinal Chemistry, 2000
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Structural analysis of hydantoins and 2-thiohydantoins in solution using 13C, 1H NMR coupling constantsJournal of Molecular Structure, 1998
- 2,4-Dinitrobenzenesulfonamides: A simple and practical method for the preparation of a variety of secondary amines and diaminesTetrahedron Letters, 1997
- The structure of hydantoins in solution and in the solid stateStructural Chemistry, 1997
- Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1996
- Synthesis of fused hydantoins by intramolecular amidoalkylationJournal of Heterocyclic Chemistry, 1974